Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer

• Publication date

  1989-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-VPMID 2910444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraperitoneal Radioactive Chromic Phosphate P 32 in the Treatment of Ovarian Cancer

  1987cited by this paper
• A reassessment of the role of second-look laparotomy in advanced ovarian cancer.

  1987cited by this paper
• Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis.

  1986cited by this paper
• Peritoneal carcinomatosis: Anatomy, physiology, diagnosis, management

  1986cited by this paper
• Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy.

  1986cited by this paper
• A strategy for intestinal obstruction of peritoneal carcinomatosis.

  1986cited by this paper
• Malignant Ascites: Clinical and Experimental Observations

  1986cited by this paper
• Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study.

  1985cited by this paper
• Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.

  1985cited by this paper
• Surgical management of intestinal obstruction in the late course of malignant disease.

  1984cited by this paper
• Bowel obstruction in cancer patients: Performance status as a predictor of survival

  1984cited by this paper
• Intraperitoneal carcinomatosis: incidence of its radiographic findings and description of a new sign.

  1983cited by this paper
• On the treatment and prognosis of malignant ascites: Is the survival time determined when the abdominal paracentesis is needed?

  1982cited by this paper
• Surgical palliation of small bowel obstruction due to metastatic carcinoma.

  1981cited by this paper
• Intestinal operations in patients with ovarian carcinoma.

  1981cited by this paper
• Intestinal obstruction in carcinomatosis.

  1980cited by this paper
• Malignant intestinal obstruction.

  1980cited by this paper
• The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis.

  1979cited by this paper
• The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis.

  1979cited by this paper
• Letter: Cardiac arrhythmia induced by phenothiazine.

  1975cited by this paper
• Small intestinal obstruction from peritoneal carcinomatosis.

  1973cited by this paper
• Delayed intestinal obstruction following treatment for cancer

  1970cited by this paper
• Implantation Peritoneal Carcinomatosis of Ovarian Origin.

  1931cited by this paper
• The pathological reaction of tissue extract (cytost) liberated in pregnancy

  1923cited by this paper

• Palliative cytoreductive surgery with hyperthermic chemotherapy for peritoneal carcinomatosis

  2025cites this paper
• Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?

  2025cites this paper
• Pressurized intraperitoneal aerosol chemotherapy in advanced gastric cancer with peritoneal metastases: a comprehensive meta-analysis of feasibility, efficacy, and safety

  2025cites this paper
• Iterative Cytoreductive Surgery and HIPEC for Peritoneal Metastases from Primary Appendiceal and Colorectal Cancers: An Observational Study

  2025cites this paper
• Evaluating the Long-Term Impact of Cytoreductive Surgery for Gastric Cancer with Peritoneal Metastasis: Are We on the Right Path?

  2025cites this paper
• The Tumor Environment in Peritoneal Carcinomatosis and Malignant Pleural Effusions: Implications for Therapy

  2025cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience

  2025cites this paper
• Role of Ancillary Techniques in Reporting Serous Fluid Cytology – “Redefining Categories, Refining Diagnosis”

  2024cites this paper
• Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer

  2024cites this paper
• Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers

  2024cites this paper
• Follow-up for More than 10 Years of Patients with Peritoneal Metastases Treated with Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy in a Specialized Unit

  2024cites this paper
• Comparison of EPIC Versus HIPEC in the Treatment of Colorectal Peritoneal Metastases and Appendix Tumors Using Inverse Probability of Treatment Weighting

  2024influential citation
• The history of cytoreduction and HIPEC: Heating up or just blowing smoke?

  2024cites this paper
• Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison

  2024cites this paper
• Prospects of the Surgical Management of Colorectal Peritoneal Metastasis.

  2024cites this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal Cancer—An Overview of Current Status and Future Perspectives

  2024cites this paper
• Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.

  2024cites this paper
• Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes

  2023cites this paper
• Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2023cites this paper
• Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease

  2023cites this paper
• Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers

  2023cites this paper
• Randomized crossover trial of ‘Roll-over’ technique of abdominal paracentesis versus standard technique in suspected malignant ascites

  2023cites this paper
• Functional biomaterials for the diagnosis and treatment of peritoneal surface malignancies

  2023cites this paper
• Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer

  2023cites this paper
• Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis

  2023cites this paper
• Epidemiology of Stage IV Colorectal Cancer: Trends in the Incidence, Prevalence, Age Distribution, and Impact on Life Span

  2023cites this paper
• Roles of ARID1A variations in colorectal cancer: a collaborative review

  2022cites this paper
• Diagnosis of Peritoneal Carcinomatosis of Colorectal Origin Based on an Innovative Fuzzy Logic Approach

  2022cites this paper
• Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities

  2022cites this paper
• Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases

  2022cites this paper
• Selection Factors for Treatment and Stratification of Rare Abdominal or Pelvic Tumors with Peritoneal Metastases

  2022cites this paper
• "When and how are peritoneal metastases of colo-rectal origin treatable".

  2022cites this paper
• Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies

  2022cites this paper
• Serous cavity metastasis: Evaluation of unknown primary

  2022cites this paper
• Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases

  2022cites this paper
• Evaluating the concept of gas‑based intraperitoneal hyperthermia beyond 43˚C in the treatment of peritoneal metastasis: A pilot study

  2022cites this paper
• The Landmark Series: Scoring Systems for Primary Peritoneal Surface Malignancy

  2022cites this paper
• Early Postoperative Extubation is Associated with Shorter Hospitalization and Improved Short-Term Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2022cites this paper
• Neutrophil to lymphocyte ratio based perioperative prediction of prognosis model on early mortality after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

  2022cites this paper
• Advances in the management of peritoneal malignancies

  2022cites this paper
• Multimodality treatment of colorectal peritoneal metastases

  2022cites this paper
• Nomogram for prediction of peritoneal metastasis risk in colorectal cancer

  2022cites this paper
• Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis

  2022cites this paper
• PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study

  2022cites this paper
• In-vivo thermodynamic exploration of gas-based intraperitoneal hyperthermia

  2022cites this paper
• Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious

  2021cites this paper
• The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis.

  2021cites this paper
• Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients

  2021cites this paper
• Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center

  2021cites this paper
• Matrix metalloproteinase-1 expression is regulated by HIF-1-dependent and epigenetic mechanisms and serves a tumor-suppressive role in gastric cancer progression

  2021cites this paper
• Primary and metastatic peritoneal surface malignancies

  2021cites this paper
• Establishment of a piglet model for peritoneal metastasis of ovarian cancer

  2021cites this paper
• Outcomes of Cytoreduction and Oxaliplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Colorectal Cancer

  2021cites this paper
• Prevalence and Clinical Implications of Ascites in Gastric Cancer Patients after Curative Surgery

  2021cites this paper
• The Role of Total Parenteral Nutrition in Patients with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Prognostic and predictive biomarkers in metastatic colorectal cancer constant and evolutionary perspectives

  2021cites this paper
• Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.

  2021cites this paper
• CMAR_A_277912 5239..5249

  2021cites this paper
• Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

  2021cites this paper
• Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

  2021cites this paper
• Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center

  2021cites this paper
• Role of intraperitoneal chemotherapy in gastric cancer

  2021cites this paper
• Preoperative Chemotherapy in Peritoneal Metastases of Tumors of the Lower GI Tract Including Appendix Carcinoma

  2021cites this paper
• Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis

  2021cites this paper
• Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study

  2020cites this paper
• Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence

  2020cites this paper
• DIAGNOSTICS, TREATMENT AND PROGNOSIS IN PATIENTS WITH COLORECTAL CANCER AND PERITONEAL CARCINOMATOSIS (review)

  2020cites this paper
• Complete remission from peritoneal metastasis of late recurrent breast cancer by endocrine therapy: a case report

  2020cites this paper
• Perforated Colorectal Cancer

  2020cites this paper
• Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients

  2020cites this paper
• Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review

  2020cites this paper
• Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer

  2020cites this paper
• Surgical management of recurrent colon cancer.

  2020cites this paper
• Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers

  2020influential citation
• Advances with pharmacotherapy for peritoneal metastasis

  2020cites this paper
• Do we still need CRS and HIPEC in colorectal cancer in times of modern chemotherapy and immunotherapy?

  2020cites this paper
• Optimization of the spatial distribution of a therapeutic pressurized aerosol (PIPAC): an ex-vivo study

  2020cites this paper
• The Role of Near-Infrared Fluorescence Imaging in the Assessment of Peritoneal Carcinomatosis from Colorectal Cancer

  2020cites this paper
• Video Atlas of Intraoperative Applications of Near Infrared Fluorescence Imaging

  2020cites this paper
• Intérêt de la chimiothérapie intrapéritonéale hyperthermique (CHIP) dans le carcinome gastrique métastatique

  2020cites this paper
• Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma

  2020cites this paper
• Recent Advances in Intra-peritoneal Chemotherapy for Gastric Cancer

  2020cites this paper
• Implications for restaging in gastric cancer with peritoneal metastasis based on the 15th Japanese Classification of Gastric Carcinoma: An analysis from a comprehensive center.

  2020cites this paper
• Afdrif þeirra sem gengist hafa undir æxlisminnkandi skurðaðgerð og hitaða lyfjameðferð innan lífhimnu

  2020cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.

  2020cites this paper
• Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta‐analysis

  2020cites this paper
• Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer

  2020cites this paper
• Perianesthesia Measurement During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Procedure: A Case Report and Review of the Literature

  2019cites this paper
• Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research

  2019cites this paper
• The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis

  2019cites this paper
• Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review

  2019cites this paper
• History of Peritoneal Surface Malignancy Treatment in Japan

  2019cites this paper
• Colorectal Cancer: Management of Stage IV Disease

  2019cites this paper
• Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.

  2019cites this paper
• Can biomarkers predict chemosensitivity in CRS-HIPEC patients?

  2019cites this paper
• Novel therapeutic approaches in peritoneal metastasis from colorectal cancer

  2019cites this paper
• Data for HIPEC in Colorectal Cancer (T4 Lesions and Metastases)

  2019cites this paper
• Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons

  2019cites this paper
• Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy used as treatment of colo-rectal carcinomatosis: a multicentric study

  2019cites this paper
• Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer.

  2019cites this paper